Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 40:1241-1247
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Päivä, H.
Right arrow Articles by Raitakari, O. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Päivä, H.
Right arrow Articles by Raitakari, O. T.

Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia

Hannu Päivä, MD*, Juha Laakso, MSc{dagger}, Hanna Laine, MD, PhD{ddagger}, Reijo Laaksonen, MD, PhD*{dagger}, Juhani Knuuti, MD, PhD§ and Olli T. Raitakari, MD, PhD§||,*

* Department of Medicine, University of Tampere, Tampere, Finland
{dagger} Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland
{ddagger} Department of Medicine, University of Turku, Turku, Finland
§ Turku PET Centre, Turku University Central Hospital, Turku, Finland
|| Department of Clinical Physiology, University of Turku, Turku, Finland



View larger version (16K):

[in a new window]
 
Figure 1 Scatterplot showing the correlation between plasma asymmetric dimethylarginine (ADMA) and hyperemic myocardial blood flow in pooled data.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement